Chronic Rhinosinusitis Nasal polyps Rhinosinusitis Nasal irrigation Hypertonic Saline Solutions Budesonide
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18 to 85 years 2. Patients was diagnosed with primary chronic rhinosinusitis according to EPOS 2020 guideline 3. Received bilateral endoscopic sinus surgery
Exclusion criteria
Exclusion criteria: 1. Pregnancy 2. Revision surgery 3. Wegener, sarcoidosis, cystic fibrosis, Kartagener 4. Previous radiotherapy to sinonasal area 5. History of hypersensitivity to budesonide 6. Patients with severe glaucoma 7. Patients with hepatic failure 8. Patients with pituitary tumour
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of inflammatory burden 1, 2, 4 and 6 weeks Lund Kennedy score,Disease specific quality of life Base line, 1, 2, 4 and 6 weeks Thai SNOT-22 | — |
Secondary
| Measure | Time frame |
|---|---|
| Nasal blockage Base line, 1, 2, 4 and 6 weeks VAS score,Alteration in sense of smell Base line, 1, 2, 4 and 6 weeks VAS score,Nasal discharge Base line, 1, 2, 4 and 6 weeks VAS score,Facial pain Base line, 1, 2, 4 and 6 weeks VAS score,Side effects Burning and dryness 1, 2, 4 and 6 weeks Record form | — |
Countries
Thailand
Contacts
Faculty of Medicine Ramathibodi Hospital, Mahidol University